Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;3(1):44-7.
doi: 10.14791/btrt.2015.3.1.44. Epub 2015 Apr 29.

The clinical characteristics of subependymal giant cell astrocytoma: five cases

Affiliations

The clinical characteristics of subependymal giant cell astrocytoma: five cases

Tae-Young Jung et al. Brain Tumor Res Treat. 2015 Apr.

Abstract

In this study, we reviewed the clinical characteristics of five cases of subependymal giant cell astrocytoma (SEGA) at our hospital between May 1997 and July 2012. The median age was 18 years old (range, 8 to 26). The clinical symptoms were presented as seizure in two patients and headache in three patients. All the tumors were located near the foramen of Monro. The median size of the tumors was 2.5 cm (range, 1.9-4.0). Two patients showed the solitary lesion, and three had subependymal nodules and cortical tubers. The median follow-up duration was 7.4 years (range, 2.0-14.3). Three patients were associated with the tuberous sclerosis complex (TSC). Four patients showed the SEGA at the first presentation and one patient experienced the 1.9 cm-sized growing mass during 7.7 years follow-up after the diagnosis of the TSC. The mass was totally removed in four patients and subtotally in one. Postoperatively, one patient took the medication for the seizure, which was controllable. The subtotally removed mass showed the recurrence postoperative 4.1 years later, and the recurred mass was stable for 4.5 years after the recurrence. The clinical follow-up study of the SEGA showed an indolent behavior before and after the surgery.

Keywords: Astrocytoma; Follow-up studies; Neurosurgery; Tuberous sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

Figures

Fig. 1
Fig. 1. Pathological findings of subependymal giant cell astrocytoma. A: Pathology shows the pleomorphic multinucleated eosinophilic tumor cells with abundant cytoplasm and these elongated tumor cells formed streams (hematoxylin and eosin staining, original magnification ×200). B: The tumor cells with abundant cytoplasm are clustered and arranged in perivascular pseudopalisading pattern (hematoxylin and eosin staining, original magnification ×100). C: The tumor cells are immune-positive for microtubule-associated protein 2 (original magnification ×200).
Fig. 2
Fig. 2. Radiological findings of case 2. A: Brain MRI shows 3 cm-sized solitary lesion near to the foramen of Monro with iso-signal intensity on T1-weighted images. B: Brain CT reveals that the mass was associated with cyst and calcification. C: The mass is subtotally removed, because of the adhesion of the hypothalamus. D: The follow-up MRI shows a 0.8 cm nodular enhancing lesion (arrow) in the right side of the septum pellucidum.
Fig. 3
Fig. 3. Radiological findings of case 4. A: Brain MRI shows the 1 cm-sized mass (arrow) adjacent to the foramen of Monro with iso-signal intensity on T1-weighted images. B: Brain MRI displays 1.9 cm-sized enlarged lesion with contrast enhancement. C: There was no recurred lesion for two years after the operation.

References

    1. Roth J, Roach ES, Bartels U, et al. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol. 2013;49:439–444. - PubMed
    1. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345–1356. - PubMed
    1. Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:243–254. - PMC - PubMed
    1. Adriaensen ME, Schaefer-Prokop CM, Stijnen T, Duyndam DA, Zonnenberg BA, Prokop M. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol. 2009;16:691–696. - PubMed
    1. Shepherd CW, Scheithauer BW, Gomez MR, Altermatt HJ, Katzmann JA. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study. Neurosurgery. 1991;28:864–868. - PubMed